latest news releases from the newsroom
Stock Market Research for Yahoo, Nextel, SBC Communications, and Bell South from StockPickReport
SHREVEPORT, La., April 4, 2005 (PRIMEZONE) -- StockPickReport.Com (IARD #119079, http://www.stockpickreport.com -- the web's only non-mainstream stock rating service), rates Yahoo!, Nextel Communications Inc., SBC Communications Inc, BellSouth Corporation.
StockPickReport: Investing Advice for Elan, Qualcomm, Texas Instruments, and Charter Communications from StockPickReport
SHREVEPORT, La., April 4, 2005 (PRIMEZONE) -- StockPickReport.Com (IARD #119079, http://www.stockpickreport.com - the web's only non-mainstream stock rating service), rates Elan Corp Plc, QUALCOMM Incorporated, Texas Instruments Inc., Charter Communications.
Diamyd Assigns Biovitrum Development of Production Process for its Diabetes Drug GAD65, Currently in Clinical Trials
STOCKHOLM, Sweden, April 4, 2005 (PRIMEZONE) -- Diamyd Medical AB and Biovitrum AB have signed an agreement covering the market adaptation of the production process for GAD65, Diamyd's product for the treatment of diabetes. The agreement means that Biovitrum is assigned the task of adapting the purification processes required for Phase III clinical trials and commercial production. Diamyd's diabetes drug is currently being tested in three different clinical trials (Phase II). The project will commence in April and will have a duration of six months.
Technical Analysis for Lucent, Lexar Media, Xybernaut, and Merck from StockPickReport
SHREVEPORT, La., April 4, 2005 (PRIMEZONE) -- StockPickReport.Com (IARD #119079, http://www.stockpickreport.com -- the web's only non-mainstream stock rating service), rates Lucent, Lexar Media Inc, Xybernaut Corp, Merck & Co Inc.
Wits Basin Precious Minerals
Wits Basin Announces European Meetings
MINNEAPOLIS, April 4, 2005 (PRIMEZONE) -- Wits Basin Precious Minerals Inc. (OTCBB:WITM) is pleased to announce that certain of its senior management team will be traveling to the United Kingdom and Switzerland in order to meet with members of the European investment community.
Neoware Acquires Qualystem Technology S.A.S.
KING OF PRUSSIA, Pa. and GENTILLY, France, April 4, 2005 (PRIMEZONE) -- Neoware Systems (Nasdaq:NWRE) today announced that it has acquired all of the outstanding shares of privately-held Qualystem Technology S.A.S., a software company based in Paris, France. Qualystem Technology develops and markets software that streams Windows(r) and application components on-demand from a server to personal computers. Neoware paid 3.0 million euros in cash, plus transaction costs and a potential earn-out based upon performance.
Discovery Laboratories, Inc.
Discovery Labs' Surfaxin (lucinactant) Phase 3 Results Published in Pediatrics, the Official Journal of the American Academy of Pediatrics
WARRINGTON, Pa., April 4, 2005 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announces publication of the results from its SELECT and STAR Phase 3 clinical trials for Surfaxin(r), in Pediatrics, a premier medical journal for pediatric healthcare practitioners. Published results from the SELECT and STAR trials concluded that Surfaxin provides potential advantages versus existing surfactant therapy and may be an effective therapeutic option for preterm infants at risk for Respiratory Distress Syndrome (RDS). Presentation of these data at multiple international medical congresses including the Pediatric Academic Societies, European Society for Pediatric Research and Hot Topics in Neonatology, and publication in a peer-reviewed journal such as Pediatrics validate these important studies.